There has been growing momentum among policymakers to address rising prescription drug prices. One solution is leveraging market forces to bring down costs by increasing competition through generics and biosimilars. During this webinar panelists will discuss the main opportunities and challenges of the generic and biosimilar market, how past administrations have approached this issue, and how different stakeholders, including consumers, are impacted.